Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas

References

• Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235–242.
   PubMed Web of Science ®Google Scholar
• Recher C, Coiffier B, Haioun C, et al. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. Lancet. 2011;378:1858–1867.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773–2780.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin–Frankfurt–Munster Group Trial NHL-BFM 90. Blood. 1999;94:3294–3306.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Pittaluga S, Maeda LS, et al. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med. 2013;368: 1408–1416.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Pittaluga S, Shovlin M, et al. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med. 2013;369:1915–1925.
   PubMed Web of Science ®Google Scholar
• Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–2510.
   PubMed Web of Science ®Google Scholar
• van Casteren NJ, van Santbrink EJ, van Inzen W, et al. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90:2245–2250.
   PubMed Web of Science ®Google Scholar
• Charleston JS, Hansen KR, Thyer AC, et al. Estimating human ovarian non-growing follicle number: the application of modern stereology techniques to an old problem. Hum Reprod. 2007;22:2103–2110.
   PubMed Web of Science ®Google Scholar
• Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5:e8772.
   PubMed Web of Science ®Google Scholar
• Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–1346.
   PubMed Web of Science ®Google Scholar
• Morgan S, Anderson RA, Gourley C, et al. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18:525–535.
   PubMed Web of Science ®Google Scholar
• Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68:196–202.
   PubMed Web of Science ®Google Scholar
• Wilson WH, Dunleavy K, Pittaluga S, et al. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J Clin Oncol. 2008;26:2717–2724.
   PubMed Web of Science ®Google Scholar
• Wilson WH, Jung SH, Porcu P, et al. A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012;97:758–765.
   PubMed Web of Science ®Google Scholar
• Hollander M, Wolfe DA. Nonparametric statistical methods. 2nd ed. New York: John Wiley and Sons, Inc; 1999.
   Google Scholar
• Agresti A. Categorical data analysis. New York: John Wiley and Sons, Inc.; 1990.
   Google Scholar
• Rossmanith WG, Scherbaum WA, Lauritzen C. Gonadotropin secretion during aging in postmenopausal women. Neuroendocrinology. 1991;54:211–218.
   PubMed Web of Science ®Google Scholar
• Rossmanith WG. Gonadotropin secretion during aging in women: review article. Exp Gerontol. 1995;30: 369–381.
   PubMed Web of Science ®Google Scholar
• Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278:419–424.
   PubMed Web of Science ®Google Scholar
• Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96:2532–2539.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Visser JA, Laven JS, et al. Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340–347.
   PubMed Web of Science ®Google Scholar
• Bath LE, Wallace WH, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18:2368–2374.
   PubMed Web of Science ®Google Scholar
• Lawrenz B, Fehm T, von Wolff M, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma ornon-Hodgkin-lymphoma-evaluation by using antimüllerian hormone and retrieved oocytes. Fertil Steril. 2012;98:141–144.
   PubMed Web of Science ®Google Scholar
• Soleimani R, Heytens E, Darzynkiewicz Z, et al. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011;3:782–793.
   PubMedGoogle Scholar
• Behringer K, Mueller H, Goergen H, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31:231–239.
   PubMed Web of Science ®Google Scholar
• van der Kaaij MA, Heutte N, Meijnders P, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study. J Clin Oncol. 2012;30:291–299.
   PubMed Web of Science ®Google Scholar
• Meissner J, Tichy D, Katzke V, et al. Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Ann Oncol. 2015;26:1771–1776.
   PubMed Web of Science ®Google Scholar
• Armitage JO, Fyfe MA, Lewis J. Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. J Clin Oncol. 1984;2:898–902.
   PubMed Web of Science ®Google Scholar
• Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin–Frankfurt–Munster Group. J Clin Oncol. 2003;21:1782–1789.
   PubMed Web of Science ®Google Scholar